Cargando…

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3(−) CD4(+) T Cells in Biliary Tract Cancer

PURPOSE: The clinical implications of tumor-infiltrating T cell subsets and their spatial distribution in biliary tract cancer (BTC) patients treated with gemcitabine plus cisplatin were investigated. MATERIALS AND METHODS: A total of 52 BTC patients treated with palliative gemcitabine plus cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyung-Don, Kim, Jwa Hoon, Ryu, Yeon-Mi, Kim, Danbee, Lee, Sunmin, Shin, Jaehoon, Hong, Seung-Mo, Kim, Ki-Hun, Jung, Dong‐Hwan, Song, Gi‐Won, Hwang, Dae Wook, Lee, Jae Hoon, Song, Ki Byung, Ryoo, Baek-Yeol, Jeong, Jae Ho, Kim, Kyu-pyo, Kim, Sang-Yeob, Yoo, Changhoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812013/ https://www.ncbi.nlm.nih.gov/pubmed/32878426 http://dx.doi.org/10.4143/crt.2020.704

Ejemplares similares

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
por: Yoo, Changhoon, et al.
Publicado: (2021)

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
por: Hyung, Jaewon, et al.
Publicado: (2019)

Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
por: Lee, Woohyung, et al.
Publicado: (2020)

Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
por: Kang, Junho, et al.
Publicado: (2020)

Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
por: Kang, Jihoon, et al.
Publicado: (2023)

Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
por: Kim, Bum Jun, et al.
Publicado: (2017)

Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection
por: Lim, Dong-Hoon, et al.
Publicado: (2023)

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
por: Yoo, Changhoon, et al.
Publicado: (2018)

Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)

Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Immunomodulatory Effects of Placenta-derived Mesenchymal Stem Cells on T Cells by Regulation of FoxP3 Expression
por: Kim, Soo-Hwan, et al.
Publicado: (2018)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Radiation therapy for recurrent extrahepatic bile duct cancer
por: Koh, Minji, et al.
Publicado: (2021)

Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
por: Yoo, Changhoon, et al.
Publicado: (2019)

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
por: Bang, Kyunghye, et al.
Publicado: (2021)

Stereotactic body radiation therapy for locally advanced pancreatic cancer
por: Jung, Jinhong, et al.
Publicado: (2019)

CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylation
por: Kim, Hyoung-Pyo, et al.
Publicado: (2007)

Real-world data analysis of patients with cancer of unknown primary
por: Kang, Sora, et al.
Publicado: (2021)

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
por: Yoo, Changhoon, et al.
Publicado: (2020)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Regulation of FoxP3(+) Regulatory T Cells and Th17 Cells by Retinoids
por: Kim, Chang H.
Publicado: (2008)

Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up
por: Ko, Dong-Yeob, et al.
Publicado: (2014)

Usefulness of intraductal RFA in patients with malignant biliary obstruction
por: Han, Sung Yong, et al.
Publicado: (2020)

CD4(+)CD25(high)FoxP3(+) Regulatory T-cells in Hematologic Diseases
por: Moon, Hee-Won, et al.
Publicado: (2011)

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis
por: Chae, Heejung, et al.
Publicado: (2020)

Associations of FoxP3 gene polymorphisms with severe recurrent respiratory papillomatosis in Korean patients
por: Kwon, Tack-Kyun, et al.
Publicado: (2017)

The effect of combination treatment using palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting versus dexamethasone alone in women receiving intravenous patient-controlled analgesia
por: Ryoo, Seung-hwa, et al.
Publicado: (2015)

Aneurysmectomy and graft interposition for giant thrombosed proximal internal carotid artery aneurysm: Technical details
por: Baek, Ki Dong, et al.
Publicado: (2023)

Regulatory (FoxP3(+)) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
por: Koh, Jiae, et al.
Publicado: (2020)

Optimal Population of FoxP3(+) T Cells in Tumors Requires an Antigen Priming-Dependent Trafficking Receptor Switch
por: Wang, Chuanwu, et al.
Publicado: (2012)

Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction
por: Shim, Dong Jae, et al.
Publicado: (2018)

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
por: Yoo, Changhoon, et al.
Publicado: (2019)

Safety and Efficacy of a Large-Bore Biliary Metallic Stent for Malignant Biliary Obstruction
por: Do, Min Young, et al.
Publicado: (2022)

Portal biliopathy treated with endoscopic biliary stenting
por: Jeon, Sung Jin, et al.
Publicado: (2016)

CD200R/Foxp3-mediated signalling regulates microglial activation
por: Yi, Min-Hee, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ldlp8elj7taht12qk5fpt7ti61